comparemela.com

Latest Breaking News On - News ratings for lexicon pharmaceuticals daily - Page 1 : comparemela.com

Lexicon Pharmaceuticals (NASDAQ:LXRX) Lifted to Sell at StockNews com

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a research report issued on Thursday. Several other analysts have also commented on LXRX. Leerink Partnrs reiterated an “outperform” rating on shares of Lexicon Pharmaceuticals in a report on Tuesday, April 30th. Needham & Company LLC reissued a “hold” […]

Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX) Sees Large Growth in Short Interest

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 23,440,000 shares, a growth of 16.5% from the April 15th total of 20,120,000 shares. Based on an average daily volume of 4,450,000 shares, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.